Skip to main content
SpringerLink
Log in

Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

We have examined the local and systemic effects of clorgyline, tranylcypromine and deprenyl on extracellular serotonin (5-HT) and 5-hydroxyindoleacetic acid in the raphe nuclei and in frontal cortex of awake, freely-moving rats using microdialysis. When administered through the dialysis probe, monoamine oxidase (monoamine: oxygen oxidoreductase (deaminating), E.C. 1.4.3.4., MAO) inhibitors increased 5-HT output in a dose-dependent manner in both brain areas. The effects were more pronounced in the raphe nuclei for the three MAO inhibitors at all doses assayed.

When the monoamine oxidase inhibitors were given i.p., dialysate 5-HT increased dramatically, after tranylcypromine (15 mg/kg), in raphe nuclei and frontal cortex (area under the curve (AUC) to 4 h post-treatment: 63-fold and 11-fold, respectively) whereas the effects of clorgyline (10 mg/kg) were much less pronounced (+ 47% increase in the AUC for raphe nuclei, P < 0.09; + 18% increase in the AUC for frontal cortex, n.s.). Deprenyl (2.5 mg/kg, i.p.) induced a moderate (+ 22%) increase of dialysate 5-HT from the raphe nuclei but did not cause a change in dialysate 5-HT from the frontal cortex (+ 4%). However, clorgyline, or deprenyl, dramatically increased dialysate 5-HT in animals which had been pre-treated with the above dose of deprenyl, or clorgyline, respectively, showing that the blockade of both forms of MAO results in much larger increases of extracellular 5-HT than does the blockade of either form alone.

These results indicate that: (a) deamination by MAO participates actively in the control of the extracellular concentration of 5-HT in those areas of the brain that are rich in serotoninergic nerve terminals as well as in cell bodies, (b) in vivo, brain 5-HT is deaminated preferentially by MAO-A but its full inhibition does not result in an increased release of 5-HT, in spite of a large accumulation of 5-HT in the brain tissue, (c) MAO-B deaminates 5-HT when the A-form is inhibited (in this situation, MAO-B participates actively in the control of a releasable pool of 5-HT), (d) the raphe nuclei appears to be a preferential site of action of MAO inhibitors, administered either locally or systemically. These results may help to understand the model of action of MAO inhibitors as antidepressant drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adell A, Sarna GS, Hutson PH, Curzon G (1989) An in vivo and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. Br J Pharmacol 97:206–212

    Google Scholar 

  • Adell A, Artigas F (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo microdialysis study. Naunyn-Schmiedeberg's Arch Pharmacol 343:237–244

    Google Scholar 

  • Adell A, Carceller A, Artigas F (1991) Regional distribution of extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain of freely moving rats. J Neurochem 56:709–712

    Google Scholar 

  • Adell A, Carceller A, Artigas F (1993) In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat. Effects of 8-OH-DPAT. J Neurochem 60:1673–1681

    Google Scholar 

  • Aghajanian GK, Sprouse J, Rasmussen K (1987) Physiology of the midbrain serotonin system. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp 141–149

    Google Scholar 

  • Amrein R, Allen SR, Guentert TW, Hartmann D, Lorscheid T, Schoerlin MP, Vranesic D (1989) The pharmacology of reversible monoamine oxidase inhibitors. Br J Psychiatry 155:66–71

    Google Scholar 

  • Artigas F, Adell A, Cortes R, Celada P (1991) Increased extracellular concentration of serotonin in the raphe nuclei after uptake inhibition measured with in vivo microdialysis. Secondary effects on 5-HT1A autoreceptors. Soc Neurosci Abstr 17:1488

    Google Scholar 

  • Baker GB, Le Gatt DF, Coutts RT (1984) A comparison of the effects of acute and chronic administration of phenelzine and tranylcypromine on brain concentrations of 2-phenylethylamine, p-tyramine and tryptamine in the rat. In: Boulton AA, Baker GB, Dewhurst WG, Sandler M (eds) Neurobiology of the trace amines. Humana Press, Clifton (NJ), pp 277–282

    Google Scholar 

  • Bel N, Artigas F (1992) Fluvoxamine increases preferentially extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229:101–103

    Google Scholar 

  • Blier P, De Montigny C (1985) Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 16:949–955

    Google Scholar 

  • Blier P, De Montigny C, Azzaro AJ (1986) Modification of the serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 237: 987–994

    Google Scholar 

  • Blier P, De Montigny C, Chaput Y (1987) Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S–35S

    Google Scholar 

  • Bradberry CW, Sprouse JS, Sheldon PW, Aghajanian GK, Roth RH (1991) In vitro microdialysis: a novel technique for stimulated neurotransmitter release measurements. J Neurosci Methods 36:85–90

    Google Scholar 

  • Cao Danh H, Strolin-Benedetti M, Dostert P (1984) Differential changes in monoamine oxidase A and B activity in aging rat tissues. In: Tipton KF, Dostert P, Strolin-Benedetti M (eds) Monoamine oxidase and disease. Academic Press, New York London, pp 301–317

    Google Scholar 

  • Carboni E, Di Chiara G (1989) Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32:637–645

    Google Scholar 

  • Celada P, Sarrias MJ, Artigas F (1990) Serotonin and 5-hydroxy-indoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. J Neural Transm Suppl 32:149–154

    Google Scholar 

  • Chen HY, Lin YP, Lee EHY (1992) Cholinergic and GABAergic mediations of the effects of apomorphine on serotonin neurons. Synapse 10:34–43

    Google Scholar 

  • Crespi F, Garratt JC, Sleight AJ, Marsden CA (1990) In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism. Neuroscience 35:139–144

    Google Scholar 

  • Fitzgerald LW, Kaplinsky L, Kimmelberg HK (1990) Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures. J Neurochem 55:2008–2014

    Google Scholar 

  • Fowler CJ, Tipton KF (1982) Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J Neurochem 38:733–736

    Google Scholar 

  • Fueri C, Faudon M, Héry M, Héry F (1984) Release of serotonin from perikarya in cat nodose ganglia. Brain Res 304:173–177

    Google Scholar 

  • Green AR, Youdim MBH (1975) Effects of monoamine oxidase inhibition by clorgyline, deprenyl or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Br J Pharmacol 55:415–422

    Google Scholar 

  • Hall DWR, Logan BW, Parsons GH (1969) Further studies on the inhibition of monoamine oxidase by M&B 9302 (clorgyline) I substrate specificity in various mammalian species. Biochem Pharmacol 18:1447–1454

    Google Scholar 

  • Hery F, Faudon M, Ternaux JP (1982) In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat. Brain Res Bull 8:123–129

    Google Scholar 

  • Hutson PH, Sauna GS, O'Connell MT, Curzon G (1989) Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett 100:276–280

    Google Scholar 

  • Invernizzi R, Belli S, Samanin R (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res 584:322–325

    Google Scholar 

  • Kalén P, Strecker RE, Rosengren E, Bjorklund A (1988) Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J Neurochem 51:1422–1435

    Google Scholar 

  • Kato T, Dong B, Ishii K, Kinemuchi H (1986) Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats. J Neurochem 46: 1277–1282

    Google Scholar 

  • Katz DM, Kimmelberg HK (1985) Kinetics and autoradiography of high affinity uptake of serotonin by primary astrocyte cultures. J Neurosci 5:1901–1908

    Google Scholar 

  • Kimmelberg HK, Katz DM (1985) High-affinity uptake of serotonin into immunocytochemically identified astrocytes. Science 228: 889–891

    Google Scholar 

  • Knoll J (1983) Deprenyl (selegiline): the history of its development and pharmacological action. Acta Neurol Scand Suppl 95:57–80

    Google Scholar 

  • Lai JCK, Leung TKC, Guest JF, Lim L, Davison AN (1980) The monoamine oxidase inhibitors clorgyline and l-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations. Biochem Pharmacol 29:2763–2767

    Google Scholar 

  • Levitt P, Pintar JE, Breakefield XO (1982) Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc Natl Acad Sci USA 79:6385–6389

    Google Scholar 

  • Murphy DL, Aulakh CS, Garrick NA, Sunderland T (1987) Monoamine oxidase inhibitors as antidepressants: implications for the mechanism of action of antidepressants and the psychobiology of the affective disorders and some related disorders. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp 545–552

    Google Scholar 

  • Neff NH, Yang HY, Fuentes JA (1974) The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain. In: Usdin E (ed) Neuropsychopharmacology of monoamines and their regulatory enzymes. Raven Press, New York, pp 49–57

    Google Scholar 

  • O'Carroll AM, Fowler CJ, Phillips JP, Tobbia I, Tipton KF (1983) The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn Schmiedeberg's Arch Pharmacol 322:198–202

    Google Scholar 

  • Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Sydney, Academic Press

    Google Scholar 

  • Saura J, Kettler R, Da Prada M, Richards JG (1992) Quantitative enzyme radioautography with [3H]Ro 41–1049 and [3H]Ro 19–6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs and human brain. J Neurosci 12: 1977–1999

    Google Scholar 

  • Sharp T, Zetterstrom T, Christmanson L, Ungerstedt U (1986) p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci Lett 72:320–324

    Google Scholar 

  • Sharp T, Bramwell SR, Grahame-Smith DG (1989) 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96:283–290

    Google Scholar 

  • Sleight AJ, Marsden CA, Martin KF, Palfreyman MG (1988) Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan. Br J Pharmacol 93:303–310

    Google Scholar 

  • Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotoninergic dorsal raphe neurons of 5-HT1A and 5-HT1B agonists. Synapse 1:3–9

    Google Scholar 

  • Stenström A, Hardy J, Oreland L (1987) Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species. Biochem Pharmacol 36:2931–2935

    Google Scholar 

  • The Parkinson study group (1989) Effect of deprenyl on the progression and disability in early Parkinson's disease. N Engl J Med 321:1364–1371

    Google Scholar 

  • Westlund KN, Denney RM, Kochersperger LM, Rose RM, Abell CW (1985) Distinct monoamine oxidase A and B populations in primate brain. Science 230:181–183

    Google Scholar 

  • Westlund KN, Denney RM, Rose RM, Abell CW (1988) Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neuroscience 25:439–456

    Google Scholar 

  • Willoghby J, Glover V, Sandler M (1988) Histochemical localisation of monoamine oxidase A and B in rat brain. J Neural Transm 74:29–42

    Google Scholar 

  • Wolf WA, Youdim MBH, Kuhn DM (1985) Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity? Eur J Pharmacol 109:381–387

    Google Scholar 

  • Yang HY, Neff NH (1973) β-Phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther 187:365–371

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurochemistry, C.S.I.C., Jordi Girona 18-26, E-08034, Barcelona, Spain

    Pau Celada & Francesc Artigas

Authors
  1. Pau Celada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesc Artigas
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Correspondence to F. Artigas at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Celada, P., Artigas, F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn-Schmiedeberg's Arch Pharmacol 347, 583–590 (1993). https://doi.org/10.1007/BF00166940

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00166940

Key words

Search

Navigation